- Home
- NTZ vs ECOR Comparison
NTZ vs ECOR Comparison
Compare NTZ & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- ECOR
- Stock Information
- Founded
- NTZ 1959
- ECOR 2005
- Country
- NTZ Italy
- ECOR United States
- Employees
- NTZ N/A
- ECOR N/A
- Industry
- NTZ Home Furnishings
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NTZ Consumer Discretionary
- ECOR Health Care
- Exchange
- NTZ Nasdaq
- ECOR Nasdaq
- Market Cap
- NTZ 41.6M
- ECOR 39.7M
- IPO Year
- NTZ 1993
- ECOR 2018
- Fundamental
- Price
- NTZ $2.67
- ECOR $6.95
- Analyst Decision
- NTZ
- ECOR Strong Buy
- Analyst Count
- NTZ 0
- ECOR 2
- Target Price
- NTZ N/A
- ECOR $25.50
- AVG Volume (30 Days)
- NTZ 3.3K
- ECOR 123.7K
- Earning Date
- NTZ 07-02-2025
- ECOR 08-06-2025
- Dividend Yield
- NTZ N/A
- ECOR N/A
- EPS Growth
- NTZ N/A
- ECOR N/A
- EPS
- NTZ N/A
- ECOR N/A
- Revenue
- NTZ $337,653,480.00
- ECOR $26,458,000.00
- Revenue This Year
- NTZ N/A
- ECOR $23.21
- Revenue Next Year
- NTZ N/A
- ECOR $44.10
- P/E Ratio
- NTZ N/A
- ECOR N/A
- Revenue Growth
- NTZ N/A
- ECOR 41.54
- 52 Week Low
- NTZ $2.15
- ECOR $4.47
- 52 Week High
- NTZ $6.27
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- NTZ 28.57
- ECOR 58.73
- Support Level
- NTZ $3.25
- ECOR $6.80
- Resistance Level
- NTZ $3.25
- ECOR $8.64
- Average True Range (ATR)
- NTZ 0.13
- ECOR 0.67
- MACD
- NTZ -0.07
- ECOR 0.18
- Stochastic Oscillator
- NTZ 31.90
- ECOR 51.85
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.